Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Determination of the pathway of NK cell stimulation with CpG oligonucleotides and regulation of activation by inhibitors IL-10 and IDO.
EF 2009-10
Résumé
Our body's defence system can generate two types of immune responses to cancer. The first type is called natural (innate) immunity, and the second is acquired (adaptive) immunity.
NK cells are a subset of lymphocytes with important functions in innate immunity and modulation of the adaptive immune response. Unmethylated CpG dinucleotides, present in bacterial DNA, have been shown to activate a potent immune response involving NK cells against tumours and viruses. However, inhibitors that dampen an immunotherapeutic response are also produced. We wish to elucidate the mechanisms by which CpG-mediated stimulation of NK cells is regulated. The long term goal of this project is to apply this information to find a way to effectively use CpG for cancer therapy.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
201588
Name
Guillon Laura K
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Determination of the pathway of NK cell stimulation with CpG oligonucleotides and regulation of activation by inhibitors IL-10 and IDO.
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cpg Stimulation; Cytokine Production; Cytotoxicity; Innate Immunity; Natural Killer Cells
Abstract
Our body's defence system can generate two types of immune responses to cancer. The first type is called natural (innate) immunity, and the second is acquired (adaptive) immunity.
NK cells are a subset of lymphocytes with important functions in innate immunity and modulation of the adaptive immune response. Unmethylated CpG dinucleotides, present in bacterial DNA, have been shown to activate a potent immune response involving NK cells against tumours and viruses. However, inhibitors that dampen an immunotherapeutic response are also produced. We wish to elucidate the mechanisms by which CpG-mediated stimulation of NK cells is regulated. The long term goal of this project is to apply this information to find a way to effectively use CpG for cancer therapy.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Guillon, Laura K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~